2025-05-02 11:21:50
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Brooks Laboratories Ltd Q3 FY2024 consolidated loss at Rs. 3.87 crore
Posted On : 2024-02-01 01:02:16( TIMEZONE : IST )
Brooks Laboratories Limited has reported Consolidated financial results for the period ended December 31, 2023.
Financial Results (Q3 FY2024) - QoQ Comparison
The company has reported total income of Rs. 21.9016 crores during the period ended December 31, 2023 as compared to Rs. 24.4072 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs. -3.8786 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. -1.6371 crores for the period ended September 30, 2023.
The company has reported EPS of Rs. -1.51 for the period ended December 31, 2023 as compared to Rs. -0.64 for the period ended September 30, 2023.
| Financials | Q3 FY2024 | Q2 FY2024 | % Change |
| Total Income | ₹ 21.9016 crs | ₹24.4072 crs |  -10.27% |
| Net Profit | ₹-3.8786 crs | ₹-1.6371 crs |  136.92% |
| EPS | ₹-1.51 | ₹-0.64 | 135.94% |
Financial Results (Q3 FY2024) - YoY Comparison
The company has reported total income of Rs. 21.9016 crores during the period ended December 31, 2023 as compared to Rs.15.3953 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.-3.8786 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.-9.4816 crores for the period ended December 31, 2022.
The company has reported EPS of Rs.-1.51 for the period ended December 31, 2023 as compared to Rs.-2.03 for the period ended December 31, 2022.
| Financials | Q3 FY2024 | Q3 FY2023 | % Change |
| Total Income | ₹ 21.9016 crs | ₹15.3953 crs |  42.26% |
| Net Profit | ₹-3.8786 crs | ₹-9.4816 crs |  59.09% |
| EPS | ₹-1.51 | ₹-2.03 | 25.62% |
Financial Results (9 Months Ended FY2024) - YoY Comparison
The company has reported total income of Rs.62.0663 crores during the 9 Months period ended December 31, 2023 as compared to Rs.50.7709 crores during the 9 Months period ended December 31, 2022.
The company has posted net profit / (loss) of Rs.-9.9861 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.-26.7558 crores for the 9 Months period ended December 31, 2022.
The company has reported EPS of Rs.-3.90 for the 9 Months period ended December 31, 2023 as compared to Rs.-6.72 for the 9 Months period ended December 31, 2022.
| Financials | 9 Months Ended FY2024 | 9 Months Ended FY2023 | % Change |
| Total Income | ₹62.0663 crs | ₹50.7709 crs | 22.25% |
| Net Profit | ₹-9.9861 crs | ₹-26.7558 crs | 62.68% |
| EPS | ₹-3.90 | ₹-6.72 | 41.96% |
Shares of Brooks Laboratories Limited was last trading in BSE at Rs. 148.50 as compared to the previous close of Rs. 147.30. The total number of shares traded during the day was 7475 in over 431 trades.
The stock hit an intraday high of Rs. 154.00 and intraday low of 145.60. The net turnover during the day was Rs. 1110352.00.
